1. Nicotinamide Phosphoribosyltransferase Attenuates Methotrexate Response in Juvenile Idiopathic Arthritis and In Vitro. Issue 3 (11th May 2016) Authors: Funk, RS; Singh, R; Pramann, L; Gigliotti, N; Islam, S; Heruth, DP; Ye, SQ; Chan, MA; Leeder, JS; Becker, ML Journal: Clinical and translational science Issue: Volume 9:Issue 3(2016) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ontogeny of Hepatic Drug Transporters as Quantified by LC‐MS/MS Proteomics. Issue 4 (13th August 2016) Authors: Prasad, B; Gaedigk, A; Vrana, M; Gaedigk, R; Leeder, JS; Salphati, L; Chu, X; Xiao, G; Hop, CECA; Evers, R; Gan, L; Unadkat, JD Journal: Clinical pharmacology & therapeutics Issue: Volume 100:Issue 4(2016:Oct.) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Single dose, CYP2D6 genotype‐stratified pharmacokinetic study of atomoxetine in children with ADHD. Issue 6 (12th January 2016) Authors: Brown, JT; Abdel‐Rahman, SM; van Haandel, L; Gaedigk, A; Lin, YS; Leeder, JS Journal: Clinical pharmacology & therapeutics Issue: Volume 99:Issue 6(2016:Jun.) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Why has model‐informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future. Issue 5 (4th April 2017) Authors: Darwich, AS; Ogungbenro, K; Vinks, AA; Powell, JR; Reny, J‐L; Marsousi, N; Daali, Y; Fairman, D; Cook, J; Lesko, LJ; McCune, JS; Knibbe, CAJ; de Wildt, SN; Leeder, JS; Neely, M; Zuppa, AF; Vicini, P; Aarons, L; Johnson, TN; Boiani, J Journal: Clinical pharmacology & therapeutics Issue: Volume 101:Issue 5(2017) Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P102 Alternative splicing of the SLCO1B1 transporter in paediatric liver. Issue 6 (17th May 2019) Authors: van Groen, BD; Bi, C; Gaedigk, R; Staggs, V; Tibboel, D; de Wildt, SN; Leeder, JS Journal: Archives of disease in childhood Issue: Volume 104:Issue 6(2019) Page Start: e60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Issue 2 (29th June 2015) Authors: Hicks, JK; Bishop, JR; Sangkuhl, K; Müller, DJ; Ji, Y; Leckband, SG; Leeder, JS; Graham, RL; Chiulli, DL; LLerena, A; Skaar, TC; Scott, SA; Stingl, JC; Klein, TE; Caudle, KE; Gaedigk, A Journal: Clinical pharmacology & therapeutics Issue: Volume 98:Issue 2(2015:Aug.) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. Issue 1 (3rd June 2015) Authors: Birdwell, KA; Decker, B; Barbarino, JM; Peterson, JF; Stein, CM; Sadee, W; Wang, D; Vinks, AA; He, Y; Swen, JJ; Leeder, JS; van Schaik, RHN; Thummel, KE; Klein, TE; Caudle, KE; MacPhee, IAM Journal: Clinical pharmacology & therapeutics Issue: Volume 98:Issue 1(2015:Jul.) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research. Issue 3 (22nd July 2015) Authors: Lewis, T; Dinh, J; Leeder, JS Journal: Clinical pharmacology & therapeutics Issue: Volume 98:Issue 3(2015:Sep.) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗